Akihito Sasaki

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 296 citations · Full text

Thrombosis, Dose-finding Phase 2, Cardiovascular Disease +10

Pathophysiological roles of nuclear factor kappaB (NF-kB) in pulmonary arterial hypertension: effects of synthetic selective NF-kB inhibitor IMD-0354

Susumu Hosokawa, Go Haraguchi, Akihito Sasaki et al. · Cardiovascular Research · 2013 · 96 citations · Full text

Arrhythmias Late After Repair of Tetralogy of Fallot-A Japanese Multicenter Study-

Makoto Nakazawa, Tokuko Shinohara, Akihito Sasaki et al. · Circulation Journal · 2004 · 68 citations · Full text

Roles of accumulated endogenous nitric oxide synthase inhibitors, enhanced arginase activity, and attenuated nitric oxide synthase activity in endothelial cells for pulmonary hypertension in rats

Akihito Sasaki, Shouzaburoh Doi, Shuki Mizutani et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology · 2007 · 60 citations

Hypertension, Heart Failure, Arginase Activity +15

Alterations of NOS, arginase, and DDAH protein expression in rabbit cavernous tissue after administration of cigarette smoke extract

Masatoshi Imamura, Yuma Waseda, G Marinova et al. · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · 2007 · 45 citations

Molecular Pharmacology, Urology, Erectile Dysfunction +9